Does the anatomical region predict blood loss or neurological deficits in embolized renal cancer spine metastases? A single-center experience with 31 patients

Table 2 Intraoperative blood loss

	Group	Mean	Std	p value
dHB	TSM	2.0	±0.8485	p=0.3934
	LSM	1.6	±0.2268	p=0.3934
	TSM+ch	1.9	±1.14	p=0.1429
	LSM+ch	0.9	±0.3464	p=0.1429
	TSM-ch + LSM-ch	1.831	±1.167	p=0.5704
	TSM+ch + LSM+ch	1.5667	±1.045	p=0.5704
Hb preoperatively	TSM-ch	7.218	±1.11	p=0.7517
	TSM+ch	7.367	±1.9	p=0.7517
	LSM-ch	7.209	±1.429	p=0.5852
	LSM+ch	6.60	±1.179	p=0.5852
	TSM-ch + LSM-ch	7.214	±1.249	p=0.5415
	TSM+ch + LSM+ ch	7.111	±1.676	p=0.5415
Hb postoperatively	TSM	5.345	±0.7421	p=0.7862
	TSMch	5.467	±1.372	p=0.7862
	LSM	5.418	±0.9411	p=0.5824
	LSMch	5.7	±0.9539	p=0.5824
	TSM+LSM	5.382	±0.8279	p=0.4564
	TSMch+LSMch	5.544	±1.045	p=0.4564

Intraoperative blood loss was determined based on the preoperative and postoperative hemoglobin (Hb) levels. Presented as delta (d) Hb and the absolute Hb values in the whole patient collective (TSM, LSM) and in comparison, between the patient groups without (TSM-ch, LSM-ch) and with chemotherapy (TSM+ch, LSM+ch)

ISSN: 1477-7819